Oncology research news from Australia and around the world
DNA mutations are essential to the rapid development of an array of antibody-producing immune cells…
Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome…
Cancer therapy increasingly relies on a personalised approach, where genetic changes in an individual tumour…
Innovations in cancer immunotherapy have achieved clinical success by considerably increasing the survival rate of…
Tumours send out signals that impair normal blood flow, which makes them hard to treat…
Glioblastomas (GBMs) are highly aggressive cancerous tumours of the brain and spinal cord. Brain cancers…
Many therapeutic targets escape drugability by mysterious molecular motions that cannot be precisely visualised. This…
Researchers at the Abramson Cancer Center at the University of Pennsylvania, USA, have found a way to…
Though the mutations accumulated by cancer cells occur more or less randomly, certain regions of…
The complex dynamic interactions between tumour cells and stromal cells in the tumour microenvironment are…